Summary

Global Bronchoscopy Market is expected to grow at a significant rate of around 7% during the forecast period. Bronchoscopy is an endoscopic technique for visualizing the inside of the airways for diagnostic and therapeutic purposes. An instrument is inserted into the airways, usually through the nose or mouth, or occasionally through a tracheostomy. The incidence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), and asthma are increasing worldwide. According to the World Health Organization (WHO), Chronic Obstructive Pulmonary Disease (COPD) is projected to become the third leading cause of death globally by 2030. The rising prevalence of these diseases is driving the demand for bronchoscopy procedures. Moreover, government initiatives and funding for research and development in the field of bronchoscopy have led to the development of new technologies and improved patient outcomes. For instance, according to the U.S. National Library of Medicine, on January 6, 2023, Research on trial “Bronchoscopy in determining the effect of e-cigarette smoking on biomarkers in the lungs”, which has led to increased demand for bronchoscopy procedures for the diagnosis and treatment of lung cancer.
Boston Scientific Corporation, Ambu A/S, Verathon Inc., Olympus Corporation, Richard Wolf GmbH, KARL STORZ, FUJIFILM Corporation, Teleflex Incorporated, Medtronic, HOYA Corporation are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report
“Amongst product type, rigid bronchoscopes are expected to grow with a significant CAGR during the forecast period”
Based on product type, the market is segmented into rigid bronchoscopes, flexible bronchoscopes, and others. Among these, rigid bronchoscopes are expected to grow with a significant CAGR during the forecast period. Rigid bronchoscopy is a valuable tool in the treatment of lung cancer, particularly for cases where the tumor is in the central airways and causing significant symptoms. The growing prevalence of lung cancer, which is the leading cause of cancer-related deaths worldwide, is driving the demand for rigid bronchoscopes. According to the world health organization, in 2022, approx. 2.21 million cases of lung cancer were reported around the globe.

“Amongst product usage, the bronchial treatment held a significant share of the market in 2021”
On the basis of product usage, the market is categorized into disposable equipment and reusable equipment. Among these, reusable equipment held a significant share of the market in 2021. This is mainly for carefully chosen individuals with severe asthma, Bronchial treatment is a minimally invasive bronchoscopy technique that uses a series of bronchoscopy procedures to provide regulated thermal energy to the airway wall. As per the data published in Shanghai Chest, in April 2020, more than 8,000 patients have undergone BT treatment globally.

“North America held a significant share of the market”
In 2021, North America held a significant share of the global bronchoscopy market. This is mainly attributed to major factors such as supportive government, advancing healthcare infrastructure, and increased investments in research and development for bronchoscopy devices coupled with technological advancements that are propelling the growth of this market in the North American region. For instance, on 1 July 2022, Verathon announced the release of the BFlex 2.8 Single-use Bronchoscope. BFlex single-use bronchoscopes are designed specifically for the critical needs of the ICU, OR and ED. Furthermore, the presence of well-established market players including manufacturers, suppliers, and distributors is also boosting the growth of the bronchoscopy market. Moreover, some of the companies are in the process of marketing their products on a regular basis and partnering with local suppliers to garner more market share. For instance, on December 2020, Olympus Corporation acquired Veran Medical Technologies, Inc. (“VMT”), a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million.

Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:
The global bronchoscopy market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

ページTOPに戻る

Table of Contents